Krassnig, S; Orthmann, A; Toeglhofer, AM; Wohlrab, C; Golob-Schwarzl, N; Wodlej, C; Pennauer, M; Raicht, A; Ali, KM; von Campe, G; Gogg-Kamerer, M; Logi, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J.
Eukaryotic initiation factors might not only represent novel targets for glioma therapies but might also monitor drug effectiveness
VIRCHOWS ARCH. 2017; 471: S46-S46.
[Oral Communication]
Web of Science